Part of storyline · CXMT’s DRAM and HBM production pushmostly DigiTimes
story 20 of 31If accurate, CXMT's reported decision modestly reinforces domestic-first allocation of China's DRAM supply, but its scale and implications remain unclear.
Limits of the evidence: The report is a single-source account and provides no quantity, duration, or independent confirmation of the declined inquiry or allocation decision.
What to watch
Assessment revised Oct 28, 2026
CXMT reportedly prioritizes China demand, rejecting Apple's DRAM inquiry
DigiTimesOct 28, 2026First report
First assessment, from DigiTimes
No maturity ladder applies to this desk.
Sens.ai aggregates and assesses published reporting. The assessment above is machine generated; the original sources are authoritative.